Woman Enters Plea in Deadly Missouri Wrong-Way CrashKelli Smith entered an Alford plea Monday to a reduced charge of careless and imprudent driving after her earlier involuntary manslaughter conviction was overturned.
Appeals Court Rules Against Missouri in Execution Drug Case8th U.S. Circuit Court rejected Missouri's claim that disclosing how it gets its pentobarbital could compromise its ability to obtain such chemicals for future executions.
New Device to Treat Heroin Addiction Might Be Available SoonThe device targets four specific cranial nerves that cause symptoms of pain during withdrawal.
Officials Fearful of New Deadly Drug Possibly Coming to MissouriThe drug is meant for animals such as elephants and rhinos.
Appeals Court Rejects Suit Over Missouri Execution ProtocolThe appeals court said the lawsuit failed to state a claim upon which relief could be granted.
Man Sentenced For Role in Multi-State Meth Trafficking RingA Kansas man has been sentenced to 25 years in prison without parole for participating in a four-state methamphetamine trafficking operation.
Former Lindenwood University Coach Facing Drug ChargesKenneth Dale Sims II jailed on $50,000 bond for possession of 108 grams of marijuana and drug paraphernalia.
Missouri House Advances Medical Marijuana BillThe restriction caused a split among some supporters of medical marijuana.
Gateway Foundation Backs Bill to Increase Medicaid-Eligible Drug Addiction Treatment"The Medicaid provisions the senator is trying to overturn have rendered us helpless."
Judge Rules Missouri Must Name Source of Execution Drug A Missouri judge has ruled that the state must reveal the source of the drug it uses to execute prisoners, finding that the state's Department of Corrections ``knowingly violated'' Missouri's open records law.
Anthem Slaps Lawsuit on Express Scripts over Drug PricingExpress Scripts runs prescription drug coverage for Anthem, the nation's second-largest health insurer.
Medical Pot Dispensary In Collinsville Hits One-Month MarkNumber of customers at HCI Alternatives has already doubled to nearly 180, further growth expected.